By releasing inflammatory mediators such as interferon, IL-6, IL-8, and TNF-α, these cells exacerbate vascular complications in SLE and APS, acting synergistically with NET-mediated vascular endothelial injury. The gene discussed is CXCL8; the disease is systemic lupus erythematosus.